Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (41-50 of 306) with videos related to

Pageof 31
Sort By:
JCO Oncology Practice|February 20, 2025
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of ViewAngioletta Lasagna, Patrizia Cambieri, Fausto Baldanti, et al.
International Immunopharmacology|January 7, 2021
Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virusMarzia Nuccetelli, Massimo Pieri, Francesca Gisone, et al.
Cell Death Discovery|June 6, 2020
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?Marzia Nuccetelli, Massimo Pieri, Sandro Grelli, et al.
Viruses|August 28, 2025
Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-AnalysisLorenzo Vittorio Rindi, Drieda Zaçe, Loredana Sarmati, et al.
AIDS (London, England)|April 2, 2005
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapyEmanuele Nicastri, Claudio Angeletti, Lucia Palmisano, et al.
The New Microbiologica|September 6, 2022
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: a mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021Loreta A Kondili, Massimo Andreoni, Alessio Aghemo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2015
Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ARTErica Giuliani, Lia Vassena, Maria Giovanna Desimio, et al.
Health Economics Review|October 30, 2021
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in ItalyFrancesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, et al.
Journal of Medical Virology|April 19, 2005
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAARTEmanuele Nicastri, Antonio Chiesi, Claudio Angeletti, et al.
AIDS (London, England)|December 22, 2007
Stopping antiretroviral therapy: role for therapeutic drug monitoringChiara Tommasi, Emanuele Nicastri, Angela Corpolongo, et al.
Pageof 31

Showing results (41-50 of 306) with videos related to

Sort By:
Pageof 31
JCO Oncology Practice|February 20, 2025
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of ViewAngioletta Lasagna, Patrizia Cambieri, Fausto Baldanti, et al.
International Immunopharmacology|January 7, 2021
Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virusMarzia Nuccetelli, Massimo Pieri, Francesca Gisone, et al.
Cell Death Discovery|June 6, 2020
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?Marzia Nuccetelli, Massimo Pieri, Sandro Grelli, et al.
Viruses|August 28, 2025
Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-AnalysisLorenzo Vittorio Rindi, Drieda Zaçe, Loredana Sarmati, et al.
AIDS (London, England)|April 2, 2005
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapyEmanuele Nicastri, Claudio Angeletti, Lucia Palmisano, et al.
The New Microbiologica|September 6, 2022
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: a mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021Loreta A Kondili, Massimo Andreoni, Alessio Aghemo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2015
Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ARTErica Giuliani, Lia Vassena, Maria Giovanna Desimio, et al.
Health Economics Review|October 30, 2021
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in ItalyFrancesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, et al.
Journal of Medical Virology|April 19, 2005
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAARTEmanuele Nicastri, Antonio Chiesi, Claudio Angeletti, et al.
AIDS (London, England)|December 22, 2007
Stopping antiretroviral therapy: role for therapeutic drug monitoringChiara Tommasi, Emanuele Nicastri, Angela Corpolongo, et al.
Pageof 31